Unknown OBSERVATIONAL NCT02363101

Health Outcomes and Costs (HOC) in Lung Cancer (LC) (HOC-LC)

Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer

Sponsor: Instituto Nacional de Cancer, Brazil

Updated 7 times since 2017 Last updated: Mar 3, 2015 Started: Mar 31, 2015 Primary completion: Mar 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lung Cancer, this trial is ongoing. The trial is conducted by Instituto Nacional de Cancer, Brazil and has accumulated 7 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

May 2017 — Apr 2018 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2017 — May 2017 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Cancer, Brazil
Instituto Nacional de Cardiologia de Laranjeiras

Data source: Instituto Nacional de Cancer, Brazil

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rio de Janeiro, Brazil